KOLON TISSUEGENE HIGHLIGHTS LONG-TERM SAFETY DATA AND POTENTIAL U.S. FDA PATHWAY FOR TG-C AT OARSI WORLD CONGRESS
- Written by PR Newswire
![]() |
- THE WORLD'S MOST PRESTIGIOUS OSTEOARTHRITIS SOCIETY (OARSI) HELD FOR THE FIRST TIME IN KOREA
- LONG-TERM SAFETY DATA FROM OVER 15 YEARS SUPPORT THE SAFETY PROFILE OF TG-C, WITH PRELIMINARY SIGNS OF POTENTIAL EFFICACY BENEFITS
ROCKVILLE, Md., April 28, 2025 /PRNewswire/ -- Kolon TissueGene participated in the 2025 Osteoarthritis Research...















